Search

Barry M Datlof

from Montgomery Village, MD
Age ~63
Get Report
Also known as:
Barry Mitchell Datlof
Phone and address:
9965 Lake Landing Rd, Gaithersburg, MD 20886
(301) 869-1589
Related to:
Aviva P DalofRhoda H Datlof, 95
Connected to:
Dhamyantie Datnarain, 70Cami J Dato, 55Christine M Dato, 52Joseph J Dato, 68Renato O Dato, 70Wynette D Dato, 56Mario T Datoc, 77Michael A Datoli, 77Michael W Daton, 36Ameen M Datoo, 52

Barry Datlof Phones & Addresses

  • 9965 Lake Landing Rd, Montgomery Village, MD 20886 (301) 869-1589 (301) 332-2548
  • Gaithersburg, MD
  • Delray Beach, FL
  • 3595 Triple Bend Rd, College Station, TX 77845 (979) 690-0558 (979) 690-1770
  • 2810 Cloisters Dr, College Station, TX 77845
  • Palm Beach, FL
  • La Jolla, CA
  • 9965 Lake Landing Rd, Gaithersburg, MD 20886

Work

Position: Administration/Managerial

Education

Degree: Associate degree or higher

Emails

b***[email protected]

Business Records

Name / Title
Company / Classification
Phones & Addresses
Barry Datlof
Principal
Infoweb Communications
Information Technology and Services · Computer Related Services · Computer Related Services, NEC
2810 Cloisters Dr, College Station, TX 77845
(979) 690-0558
Barry Mitchell Datlof
M
Pregmama, LLC
2508 Merrimac Ct, College Station, TX 77845

Publications

Us Patents

Hormone Normalization Therapy And Uses Therefor

View page
US Patent:
20090137478, May 28, 2009
Filed:
Nov 12, 2008
Appl. No.:
12/291639
Inventors:
Lori R. Bernstein - Montgomery Village MD, US
Barry M. Datlof - Montgomery Village MD, US
International Classification:
A61K 38/24
A61P 5/24
US Classification:
514 12
Abstract:
The present invention discloses a novel method of prevention of birth defects, miscarriages and infertility in women. The two therapies, disclosed herein, the hormone normalization therapy and the aromatase inhibitor-hormone normalization therapy, focus on restoring young hormonal levels in women in order to prevent female infertility and miscarriages, guide follicular and oocyte maturation, and promote correct chromosomal segregation in oocytes and early embryos.

Hormone Normalization Therapy And Uses Therefor

View page
US Patent:
20150273020, Oct 1, 2015
Filed:
Jun 15, 2015
Appl. No.:
14/739333
Inventors:
Lori R. Bernstein - Montgomery Village MD, US
Barry M. Datlof - Montgomery Village MD, US
International Classification:
A61K 38/24
A61K 38/08
A61K 31/57
A61K 31/573
A61K 31/585
A61K 31/536
A61K 31/566
A61K 31/437
A61K 31/4196
A61K 31/4545
A61K 31/565
A61K 31/09
A61K 31/05
A61K 31/661
A61K 31/567
A61K 38/09
Abstract:
The present invention discloses methods of prevention of oocyte and fetal aneuploidy, birth defects, miscarriages and infertility in women. The three therapies, disclosed herein, the hormone normalization therapy, the aromatase inhibitor-hormone normalization therapy, and the low responder hormone normalization therapy with estrogenic supplementation focus on restoring young hormonal levels in women in order to prevent female infertility and miscarriages, guide follicular and oocyte maturation, follicular responsiveness, and promote correct chromosomal segregation in oocytes and early embryos.
Control profile
Barry M Datlof from Montgomery Village, MD, age ~63 Get Report